- Published on
Emergency and Acute Medicine – Paraphimosis
Paraphimosis is a urologic emergency defined by entrapment of the retracted foreskin proximal to the glans penis. This entrapment leads to progressive lymphatic congestion and venous obstruction, which can ultimately compromise arterial blood flow to the glans. If not promptly recognized and treated, paraphimosis may result in ischemia, necrosis, and permanent penile injury.
The condition most commonly occurs when the foreskin is retracted and not returned to its normal position. Predisposing factors include phimosis, inflammation, trauma, and sexual inexperience, particularly in individuals unaware of the need to reduce the foreskin after intercourse. Paraphimosis is frequently iatrogenic, occurring after physical examination, urinary catheterization, cystoscopy, or genital hygiene when the foreskin is left retracted.
Patients typically present with penile pain, a visibly retracted foreskin, and a swollen, edematous glans. The glans may appear erythematous, dusky, or cyanotic as venous congestion progresses. Local cellulitis may be present, and in advanced or untreated cases, necrosis of the glans can develop. Physical examination should include careful inspection of the entire penis to exclude constricting foreign bodies or bands, such as hair tourniquets, wire, or string, which can mimic paraphimosis.
The diagnosis of paraphimosis is clinical and should be made based on history and physical examination alone. Treatment must not be delayed for laboratory or imaging studies. Imaging is generally unnecessary unless a foreign body is suspected, in which case radiographs may be obtained after restoration of adequate perfusion.
Initial management focuses on rapid reduction of edema and prompt return of the foreskin to its normal position to restore blood flow. Pain control is essential and may require local anesthesia, a penile nerve block, systemic analgesia, or conscious sedation, especially in children. Ice packs may be applied to the glans to reduce swelling while preparations for reduction are made. Manual reduction is the first-line treatment and involves circumferential compression of the edematous glans while simultaneously applying traction to advance the foreskin distally over the glans.
If manual reduction is unsuccessful, additional techniques may be employed to reduce edema. These include the multiple puncture technique, in which small-gauge needle punctures are made in the swollen foreskin to allow expression of edema fluid, followed by another attempt at manual reduction. Osmotic methods, such as application of gauze soaked in 50% dextrose, may also help decrease edema if immediate reduction is delayed. When noninvasive methods fail, a dorsal slit of the foreskin may be required to release the constricting ring. In some cases, suturing may be necessary after reduction if the incision is extensive.
Antibiotics are generally not required unless there is associated cellulitis or balanoposthitis. Once reduction is successful and symptoms resolve, most patients can be discharged with close urologic follow-up. Admission is indicated for patients with penile necrosis, severe infection, or inability to achieve reduction. Urologic consultation is recommended in all cases, and circumcision may be considered to prevent recurrence, although this remains a topic of clinical debate.
Patient education is essential to prevent recurrence. Patients should be instructed on proper foreskin hygiene and the importance of returning the foreskin to its normal position after retraction for cleaning, sexual activity, or medical procedures. Early recognition and prompt management are key to preventing serious complications of paraphimosis.
Paraphimosis is a urologic emergency defined by entrapment of the retracted foreskin proximal to the glans penis. This entrapment leads to progressive lymphatic congestion and venous obstruction, which can ultimately compromise arterial blood flow to the glans. If not promptly recognized and treated, paraphimosis may result in ischemia, necrosis, and permanent penile injury.
The condition most commonly occurs when the foreskin is retracted and not returned to its normal position. Predisposing factors include phimosis, inflammation, trauma, and sexual inexperience, particularly in individuals unaware of the need to reduce the foreskin after intercourse. Paraphimosis is frequently iatrogenic, occurring after physical examination, urinary catheterization, cystoscopy, or genital hygiene when the foreskin is left retracted.
Patients typically present with penile pain, a visibly retracted foreskin, and a swollen, edematous glans. The glans may appear erythematous, dusky, or cyanotic as venous congestion progresses. Local cellulitis may be present, and in advanced or untreated cases, necrosis of the glans can develop. Physical examination should include careful inspection of the entire penis to exclude constricting foreign bodies or bands, such as hair tourniquets, wire, or string, which can mimic paraphimosis.
The diagnosis of paraphimosis is clinical and should be made based on history and physical examination alone. Treatment must not be delayed for laboratory or imaging studies. Imaging is generally unnecessary unless a foreign body is suspected, in which case radiographs may be obtained after restoration of adequate perfusion.
Initial management focuses on rapid reduction of edema and prompt return of the foreskin to its normal position to restore blood flow. Pain control is essential and may require local anesthesia, a penile nerve block, systemic analgesia, or conscious sedation, especially in children. Ice packs may be applied to the glans to reduce swelling while preparations for reduction are made. Manual reduction is the first-line treatment and involves circumferential compression of the edematous glans while simultaneously applying traction to advance the foreskin distally over the glans.
If manual reduction is unsuccessful, additional techniques may be employed to reduce edema. These include the multiple puncture technique, in which small-gauge needle punctures are made in the swollen foreskin to allow expression of edema fluid, followed by another attempt at manual reduction. Osmotic methods, such as application of gauze soaked in 50% dextrose, may also help decrease edema if immediate reduction is delayed. When noninvasive methods fail, a dorsal slit of the foreskin may be required to release the constricting ring. In some cases, suturing may be necessary after reduction if the incision is extensive.
Antibiotics are generally not required unless there is associated cellulitis or balanoposthitis. Once reduction is successful and symptoms resolve, most patients can be discharged with close urologic follow-up. Admission is indicated for patients with penile necrosis, severe infection, or inability to achieve reduction. Urologic consultation is recommended in all cases, and circumcision may be considered to prevent recurrence, although this remains a topic of clinical debate.
Patient education is essential to prevent recurrence. Patients should be instructed on proper foreskin hygiene and the importance of returning the foreskin to its normal position after retraction for cleaning, sexual activity, or medical procedures. Early recognition and prompt management are key to preventing serious complications of paraphimosis.
- Published on
Emergency and Acute Medicine – Panic Attack
Panic attacks are characterized by sudden episodes of intense fear accompanied by prominent physical symptoms that peak rapidly, usually within 10 minutes, and resolve within approximately 20–30 minutes. Some patients, particularly those with medical illness, may experience a nonfearful variant dominated by somatic symptoms. Panic disorder is defined by recurrent, unexpected panic attacks followed by at least one month of persistent concern about additional attacks, worry about their implications, or maladaptive behavioral changes such as avoidance. Panic disorder may occur with or without agoraphobia, which reflects anxiety related to fear of being unable to escape or obtain help. The condition is often episodic or chronic and is frequently comorbid with depression, substance use disorders, functional disability, and increased suicidal risk.
The underlying mechanism involves dysregulation of the limbic system with excessive norepinephrine release and altered serotonergic and benzodiazepine receptor function, triggering a maladaptive “fight-or-flight” response. Genetic factors play an important role, with family history of panic or anxiety disorders commonly reported. Risk factors include major life stressors in the year preceding onset, childhood shyness or separation anxiety, female sex, and stimulant use such as cocaine. Panic attacks may initially arise in the context of physical illness or substance use and persist even after the precipitating condition has resolved.
Clinical presentation reflects widespread autonomic activation. Cardiac symptoms include palpitations, tachycardia, and chest discomfort. Respiratory complaints such as shortness of breath, choking sensations, or smothering feelings are common. Neurologic and systemic symptoms include tremor, dizziness, lightheadedness, paresthesias, sweating, chills, flushing, and feelings of unreality or depersonalization. Gastrointestinal symptoms such as nausea, cramping, and abdominal pain may occur. Intense, stereotyped fears often center on imminent death, having a heart attack, losing control, or “going crazy.” A thorough history should explore medical conditions, medications (including over-the-counter and herbal products), substance and caffeine use, age at onset, triggering stressors, avoidance behaviors, prior treatment response, and family history of anxiety or substance use.
Physical examination should be complete and focused on cardiopulmonary and neurologic systems, guided by presenting symptoms. The essential workup is individualized and often minimal, aimed at excluding organic causes suggested by the history or exam. Laboratory evaluation may include basic metabolic studies, glucose, thyroid-stimulating hormone, and toxicology screening. Electrocardiography is appropriate for patients over 40 years of age, those with cardiac symptoms, or those taking tricyclic antidepressants. Additional testing such as Holter monitoring, arterial blood gases, or EEG is reserved for specific indications.
The differential diagnosis is broad and must be carefully considered, particularly in first presentations, late-onset cases, or atypical features. Cardiopulmonary causes include myocardial ischemia, arrhythmias, pulmonary embolism, asthma, and pneumonia. Metabolic and endocrine disorders include hypoglycemia, hyperthyroidism, electrolyte abnormalities, and pheochromocytoma. Neurologic conditions such as seizures or transient ischemic attack, medication effects, substance intoxication or withdrawal, and other psychiatric disorders including PTSD, obsessive-compulsive disorder, and somatoform disorders must also be considered.
Initial management focuses on calm reassurance and patient education. Most panic attacks resolve spontaneously, and excessive medical intervention may reinforce fear. Explaining the physiologic basis of symptoms can reduce distress and interrupt the cycle of escalating anxiety. In the emergency department, short-acting, high-potency benzodiazepines may be used for severe or persistent symptoms. Lorazepam is often preferred due to its rapid onset and smoother offset. Clonazepam is effective but has a slower onset and is better suited for maintenance therapy rather than acute control. Alprazolam should generally be avoided due to rapid offset and risk of rebound anxiety. Long-term management of recurrent panic attacks or panic disorder relies on cognitive–behavioral therapy and selective serotonin reuptake inhibitors, which should be initiated in the outpatient setting when follow-up is assured.
Admission is rarely required unless needed to exclude a serious medical condition or for psychiatric indications such as suicidality. Most patients can be safely discharged once symptoms resolve, with reassurance and clear follow-up plans. Referral to primary care or mental health services is recommended for recurrent attacks, interepisode anxiety, or avoidance behaviors. Patients should be counseled to avoid triggers such as caffeine, stimulants, and alcohol. Key pearls include recognizing that panic attacks are self-limited, maintaining a calm clinical approach, using medications judiciously, and emphasizing nonpharmacologic strategies such as cognitive–behavioral therapy to achieve durable symptom control.
Panic attacks are characterized by sudden episodes of intense fear accompanied by prominent physical symptoms that peak rapidly, usually within 10 minutes, and resolve within approximately 20–30 minutes. Some patients, particularly those with medical illness, may experience a nonfearful variant dominated by somatic symptoms. Panic disorder is defined by recurrent, unexpected panic attacks followed by at least one month of persistent concern about additional attacks, worry about their implications, or maladaptive behavioral changes such as avoidance. Panic disorder may occur with or without agoraphobia, which reflects anxiety related to fear of being unable to escape or obtain help. The condition is often episodic or chronic and is frequently comorbid with depression, substance use disorders, functional disability, and increased suicidal risk.
The underlying mechanism involves dysregulation of the limbic system with excessive norepinephrine release and altered serotonergic and benzodiazepine receptor function, triggering a maladaptive “fight-or-flight” response. Genetic factors play an important role, with family history of panic or anxiety disorders commonly reported. Risk factors include major life stressors in the year preceding onset, childhood shyness or separation anxiety, female sex, and stimulant use such as cocaine. Panic attacks may initially arise in the context of physical illness or substance use and persist even after the precipitating condition has resolved.
Clinical presentation reflects widespread autonomic activation. Cardiac symptoms include palpitations, tachycardia, and chest discomfort. Respiratory complaints such as shortness of breath, choking sensations, or smothering feelings are common. Neurologic and systemic symptoms include tremor, dizziness, lightheadedness, paresthesias, sweating, chills, flushing, and feelings of unreality or depersonalization. Gastrointestinal symptoms such as nausea, cramping, and abdominal pain may occur. Intense, stereotyped fears often center on imminent death, having a heart attack, losing control, or “going crazy.” A thorough history should explore medical conditions, medications (including over-the-counter and herbal products), substance and caffeine use, age at onset, triggering stressors, avoidance behaviors, prior treatment response, and family history of anxiety or substance use.
Physical examination should be complete and focused on cardiopulmonary and neurologic systems, guided by presenting symptoms. The essential workup is individualized and often minimal, aimed at excluding organic causes suggested by the history or exam. Laboratory evaluation may include basic metabolic studies, glucose, thyroid-stimulating hormone, and toxicology screening. Electrocardiography is appropriate for patients over 40 years of age, those with cardiac symptoms, or those taking tricyclic antidepressants. Additional testing such as Holter monitoring, arterial blood gases, or EEG is reserved for specific indications.
The differential diagnosis is broad and must be carefully considered, particularly in first presentations, late-onset cases, or atypical features. Cardiopulmonary causes include myocardial ischemia, arrhythmias, pulmonary embolism, asthma, and pneumonia. Metabolic and endocrine disorders include hypoglycemia, hyperthyroidism, electrolyte abnormalities, and pheochromocytoma. Neurologic conditions such as seizures or transient ischemic attack, medication effects, substance intoxication or withdrawal, and other psychiatric disorders including PTSD, obsessive-compulsive disorder, and somatoform disorders must also be considered.
Initial management focuses on calm reassurance and patient education. Most panic attacks resolve spontaneously, and excessive medical intervention may reinforce fear. Explaining the physiologic basis of symptoms can reduce distress and interrupt the cycle of escalating anxiety. In the emergency department, short-acting, high-potency benzodiazepines may be used for severe or persistent symptoms. Lorazepam is often preferred due to its rapid onset and smoother offset. Clonazepam is effective but has a slower onset and is better suited for maintenance therapy rather than acute control. Alprazolam should generally be avoided due to rapid offset and risk of rebound anxiety. Long-term management of recurrent panic attacks or panic disorder relies on cognitive–behavioral therapy and selective serotonin reuptake inhibitors, which should be initiated in the outpatient setting when follow-up is assured.
Admission is rarely required unless needed to exclude a serious medical condition or for psychiatric indications such as suicidality. Most patients can be safely discharged once symptoms resolve, with reassurance and clear follow-up plans. Referral to primary care or mental health services is recommended for recurrent attacks, interepisode anxiety, or avoidance behaviors. Patients should be counseled to avoid triggers such as caffeine, stimulants, and alcohol. Key pearls include recognizing that panic attacks are self-limited, maintaining a calm clinical approach, using medications judiciously, and emphasizing nonpharmacologic strategies such as cognitive–behavioral therapy to achieve durable symptom control.
- Published on
Emergency and Acute Medicine – Pediculosis
Pediculosis is an infestation caused by lice that live in close association with humans. Bites are typically painless, and symptoms arise from the host’s inflammatory response to saliva and anticoagulants injected during feeding. Transmission occurs through direct contact and fomites such as combs, pillows, hats, and clothing. Head lice spread primarily through head-to-head contact and are more common in children and females. Pubic lice are usually transmitted through sexual contact. All lice are obligate human parasites and generally cannot survive away from a host for more than 7–10 days.
The condition is caused by three main species. *Pediculus capitis* (head lice) is the most common and affects all socioeconomic groups. *Pediculus corporis* (body lice) is associated with poor hygiene, poverty, and overcrowding, living primarily in clothing seams and transferring to the skin for feeding. *Phthirus pubis* (pubic or crab lice) typically infests coarse hair in the pubic region and is sexually transmitted. In children, pubic lice should raise concern for possible sexual abuse.
Clinical presentation varies by type. Head lice may cause scalp pruritus or be asymptomatic, often mistaken for dandruff. Body lice present with pruritus and excoriations, especially along clothing seams. Pubic lice cause intense itching, often worse at night. Physical examination focuses on identifying live lice or nits cemented to hair shafts, which cannot be easily brushed off. Empty nits alone do not confirm active infestation. Findings may include erythema, excoriations, secondary bacterial infection, posterior cervical lymphadenopathy, or bluish macules (maculae ceruleae) in pubic lice. Body lice are confirmed by finding nits in clothing seams rather than on the skin.
Diagnosis is clinical, based on careful history and physical examination with universal precautions. Laboratory testing is rarely necessary, although nits may be visualized under low-power microscopy and may fluoresce under a Wood lamp. Imaging has no role. Differential diagnoses include scabies, contact or allergic dermatitis, seborrheic dermatitis, and bed bug bites.
Management is primarily outpatient and supportive. Pruritus may be relieved with oral antihistamines or topical steroids. Head lice are treated with topical pediculicides such as permethrin 1% cream rinse or pyrethrin-based products, with nit removal using a fine-toothed comb. Reapplication in 7–10 days is usually required due to incomplete ovicidal activity. All household contacts should be examined, and infested individuals treated. Clothing, bedding, towels, and headgear should be washed and dried using hot cycles, and personal items such as combs and brushes disinfected.
Body lice management emphasizes hygiene, laundering clothing and bedding at high temperatures, and applying topical pediculicides when needed. Pubic lice are treated with topical pediculicides applied to affected hair-bearing areas, with simultaneous treatment of sexual contacts. Eyelash involvement is managed with petrolatum applied twice daily for several days. Second-line agents such as ivermectin or spinosad may be used for resistant cases.
Admission is rarely required and is reserved for patients with extensive bacterial superinfection or severe hypersensitivity reactions. Most patients can be discharged after treatment with appropriate education. Children may return to school after initial therapy, provided repeat treatment is completed. Follow-up is recommended to ensure eradication and to address social or safeguarding concerns when indicated.
Key points include confirming diagnosis by direct visualization, repeating treatment after 7–10 days, thorough environmental decontamination, and awareness of increasing resistance to first-line agents. Lindane is no longer recommended due to toxicity, and second-line treatments are effective but more costly.
Pediculosis is an infestation caused by lice that live in close association with humans. Bites are typically painless, and symptoms arise from the host’s inflammatory response to saliva and anticoagulants injected during feeding. Transmission occurs through direct contact and fomites such as combs, pillows, hats, and clothing. Head lice spread primarily through head-to-head contact and are more common in children and females. Pubic lice are usually transmitted through sexual contact. All lice are obligate human parasites and generally cannot survive away from a host for more than 7–10 days.
The condition is caused by three main species. *Pediculus capitis* (head lice) is the most common and affects all socioeconomic groups. *Pediculus corporis* (body lice) is associated with poor hygiene, poverty, and overcrowding, living primarily in clothing seams and transferring to the skin for feeding. *Phthirus pubis* (pubic or crab lice) typically infests coarse hair in the pubic region and is sexually transmitted. In children, pubic lice should raise concern for possible sexual abuse.
Clinical presentation varies by type. Head lice may cause scalp pruritus or be asymptomatic, often mistaken for dandruff. Body lice present with pruritus and excoriations, especially along clothing seams. Pubic lice cause intense itching, often worse at night. Physical examination focuses on identifying live lice or nits cemented to hair shafts, which cannot be easily brushed off. Empty nits alone do not confirm active infestation. Findings may include erythema, excoriations, secondary bacterial infection, posterior cervical lymphadenopathy, or bluish macules (maculae ceruleae) in pubic lice. Body lice are confirmed by finding nits in clothing seams rather than on the skin.
Diagnosis is clinical, based on careful history and physical examination with universal precautions. Laboratory testing is rarely necessary, although nits may be visualized under low-power microscopy and may fluoresce under a Wood lamp. Imaging has no role. Differential diagnoses include scabies, contact or allergic dermatitis, seborrheic dermatitis, and bed bug bites.
Management is primarily outpatient and supportive. Pruritus may be relieved with oral antihistamines or topical steroids. Head lice are treated with topical pediculicides such as permethrin 1% cream rinse or pyrethrin-based products, with nit removal using a fine-toothed comb. Reapplication in 7–10 days is usually required due to incomplete ovicidal activity. All household contacts should be examined, and infested individuals treated. Clothing, bedding, towels, and headgear should be washed and dried using hot cycles, and personal items such as combs and brushes disinfected.
Body lice management emphasizes hygiene, laundering clothing and bedding at high temperatures, and applying topical pediculicides when needed. Pubic lice are treated with topical pediculicides applied to affected hair-bearing areas, with simultaneous treatment of sexual contacts. Eyelash involvement is managed with petrolatum applied twice daily for several days. Second-line agents such as ivermectin or spinosad may be used for resistant cases.
Admission is rarely required and is reserved for patients with extensive bacterial superinfection or severe hypersensitivity reactions. Most patients can be discharged after treatment with appropriate education. Children may return to school after initial therapy, provided repeat treatment is completed. Follow-up is recommended to ensure eradication and to address social or safeguarding concerns when indicated.
Key points include confirming diagnosis by direct visualization, repeating treatment after 7–10 days, thorough environmental decontamination, and awareness of increasing resistance to first-line agents. Lindane is no longer recommended due to toxicity, and second-line treatments are effective but more costly.
- Published on
Emergency and Acute Medicine – Pelvic Fracture
Pelvic fractures account for approximately 3% of all bony fractures but are associated with disproportionately high morbidity and mortality. The pelvis consists of the sacrum and two innominate bones, each formed by the ilium, ischium, and pubis. Stability of the pelvic ring depends on strong ligamentous, muscular, and soft tissue support. The anterior pelvis is stabilized by the symphysis pubis and pubic rami, while posterior stability is provided by the sacroiliac (SI) complex and pelvic floor. Because the pelvis protects major vascular structures as well as genitourinary, gastrointestinal, gynecologic, neurologic, and musculoskeletal systems, fractures often coexist with life-threatening injuries and require urgent recognition and management.
Most pelvic fractures result from high-energy trauma. Approximately 65% are caused by vehicular mechanisms, including pedestrians struck by automobiles, while falls and crush injuries account for another 20%. Athletic, penetrating, and nontraumatic causes are less common. Mortality ranges from 6–19% and increases significantly in open fractures or when hemorrhagic shock is present. Unstable fractures, particularly those involving the posterior pelvis, are prone to severe hemorrhage due to disruption of arterial branches and venous plexuses, often with associated retroperitoneal hematoma. In children, hemorrhage may be more severe, and nonaccidental trauma must be considered. In pregnancy, pelvic fractures pose additional risk to the gravid uterus, including uterine rupture.
Clinically, patients typically present with pelvic, hip, groin, or lower back pain, often accompanied by swelling, ecchymosis, and tenderness. Many have associated injuries involving the abdomen, genitourinary tract, neurologic system, or vascular structures. Signs of pelvic instability, deformity, limb shortening or rotation, and inability to bear weight are concerning. In severe cases, hemorrhagic shock may dominate the presentation, with tachycardia, hypotension, altered mental status, and cool, pale extremities. Bleeding from the urethra, rectum, or vagina, as well as open wounds over the pelvis, suggests an open pelvic fracture.
Initial evaluation follows standard trauma principles. A single anteroposterior (AP) pelvic radiograph is the most important early diagnostic test and should be obtained promptly when pelvic fracture is suspected. Additional views such as inlet, outlet, or Judet oblique projections may further define injury patterns, particularly involving the posterior pelvis or acetabulum. Computed tomography (CT) provides detailed assessment of fracture anatomy, retroperitoneal hematoma, and associated visceral injuries, and CT angiography can identify arterial bleeding in hemodynamically stable patients. Focused abdominal sonography for trauma (FAST) may help detect intraperitoneal bleeding but has limited ability to distinguish pelvic from abdominal sources. Laboratory studies include type and cross-match, hemoglobin and hematocrit, platelet count, and coagulation profile.
Pelvic fractures are commonly categorized using the Tile classification system, which helps guide management. Type A fractures are stable and include avulsion injuries, isolated pubic rami fractures, and transverse sacral fractures. Type B fractures are rotationally unstable but vertically stable, such as open-book and lateral compression injuries. Type C fractures are both rotationally and vertically unstable, including vertical shear (Malgaigne) fractures, and are associated with the highest risk of hemorrhage and mortality. Acetabular fractures represent a distinct subgroup requiring specialized orthopedic evaluation.
Management priorities focus on rapid resuscitation, hemorrhage control, and stabilization. Early application of a pelvic binder or improvised sheet wrap at the level of the greater trochanters is critical in suspected unstable fractures, as it reduces pelvic volume and limits bleeding. Fluid resuscitation with crystalloids and early blood transfusion is indicated for shock, avoiding lower extremity IV access when possible. External fixation, angiographic embolization, or surgical pelvic packing may be required for ongoing hemorrhage. Type A fractures are generally managed conservatively with analgesia and mobilization as tolerated, whereas Type B and C fractures require urgent orthopedic and trauma consultation, close monitoring, and often operative intervention.
Patients with hemodynamic instability, unstable pelvic fractures, acetabular fractures, pelvic hemorrhage, or associated injuries should be admitted, frequently to the intensive care unit. Hemodynamically stable patients with isolated, stable Type A fractures and no other injuries may be discharged with appropriate analgesia and close orthopedic follow-up. A key clinical principle is that pelvic fractures signal high-energy trauma; clinicians must maintain a high index of suspicion for associated abdominal, genitourinary, vascular, and neurologic injuries. Early stabilization of the pelvis and management decisions guided by hemodynamic status are essential to improving outcomes.
Pelvic fractures account for approximately 3% of all bony fractures but are associated with disproportionately high morbidity and mortality. The pelvis consists of the sacrum and two innominate bones, each formed by the ilium, ischium, and pubis. Stability of the pelvic ring depends on strong ligamentous, muscular, and soft tissue support. The anterior pelvis is stabilized by the symphysis pubis and pubic rami, while posterior stability is provided by the sacroiliac (SI) complex and pelvic floor. Because the pelvis protects major vascular structures as well as genitourinary, gastrointestinal, gynecologic, neurologic, and musculoskeletal systems, fractures often coexist with life-threatening injuries and require urgent recognition and management.
Most pelvic fractures result from high-energy trauma. Approximately 65% are caused by vehicular mechanisms, including pedestrians struck by automobiles, while falls and crush injuries account for another 20%. Athletic, penetrating, and nontraumatic causes are less common. Mortality ranges from 6–19% and increases significantly in open fractures or when hemorrhagic shock is present. Unstable fractures, particularly those involving the posterior pelvis, are prone to severe hemorrhage due to disruption of arterial branches and venous plexuses, often with associated retroperitoneal hematoma. In children, hemorrhage may be more severe, and nonaccidental trauma must be considered. In pregnancy, pelvic fractures pose additional risk to the gravid uterus, including uterine rupture.
Clinically, patients typically present with pelvic, hip, groin, or lower back pain, often accompanied by swelling, ecchymosis, and tenderness. Many have associated injuries involving the abdomen, genitourinary tract, neurologic system, or vascular structures. Signs of pelvic instability, deformity, limb shortening or rotation, and inability to bear weight are concerning. In severe cases, hemorrhagic shock may dominate the presentation, with tachycardia, hypotension, altered mental status, and cool, pale extremities. Bleeding from the urethra, rectum, or vagina, as well as open wounds over the pelvis, suggests an open pelvic fracture.
Initial evaluation follows standard trauma principles. A single anteroposterior (AP) pelvic radiograph is the most important early diagnostic test and should be obtained promptly when pelvic fracture is suspected. Additional views such as inlet, outlet, or Judet oblique projections may further define injury patterns, particularly involving the posterior pelvis or acetabulum. Computed tomography (CT) provides detailed assessment of fracture anatomy, retroperitoneal hematoma, and associated visceral injuries, and CT angiography can identify arterial bleeding in hemodynamically stable patients. Focused abdominal sonography for trauma (FAST) may help detect intraperitoneal bleeding but has limited ability to distinguish pelvic from abdominal sources. Laboratory studies include type and cross-match, hemoglobin and hematocrit, platelet count, and coagulation profile.
Pelvic fractures are commonly categorized using the Tile classification system, which helps guide management. Type A fractures are stable and include avulsion injuries, isolated pubic rami fractures, and transverse sacral fractures. Type B fractures are rotationally unstable but vertically stable, such as open-book and lateral compression injuries. Type C fractures are both rotationally and vertically unstable, including vertical shear (Malgaigne) fractures, and are associated with the highest risk of hemorrhage and mortality. Acetabular fractures represent a distinct subgroup requiring specialized orthopedic evaluation.
Management priorities focus on rapid resuscitation, hemorrhage control, and stabilization. Early application of a pelvic binder or improvised sheet wrap at the level of the greater trochanters is critical in suspected unstable fractures, as it reduces pelvic volume and limits bleeding. Fluid resuscitation with crystalloids and early blood transfusion is indicated for shock, avoiding lower extremity IV access when possible. External fixation, angiographic embolization, or surgical pelvic packing may be required for ongoing hemorrhage. Type A fractures are generally managed conservatively with analgesia and mobilization as tolerated, whereas Type B and C fractures require urgent orthopedic and trauma consultation, close monitoring, and often operative intervention.
Patients with hemodynamic instability, unstable pelvic fractures, acetabular fractures, pelvic hemorrhage, or associated injuries should be admitted, frequently to the intensive care unit. Hemodynamically stable patients with isolated, stable Type A fractures and no other injuries may be discharged with appropriate analgesia and close orthopedic follow-up. A key clinical principle is that pelvic fractures signal high-energy trauma; clinicians must maintain a high index of suspicion for associated abdominal, genitourinary, vascular, and neurologic injuries. Early stabilization of the pelvis and management decisions guided by hemodynamic status are essential to improving outcomes.
- Published on
Emergency and Acute Medicine – Pelvic Fracture
Pelvic fractures account for approximately 3% of all bony fractures but are associated with disproportionately high morbidity and mortality. The pelvis consists of the sacrum and two innominate bones, each formed by the ilium, ischium, and pubis. Stability of the pelvic ring depends on strong ligamentous, muscular, and soft tissue support. The anterior pelvis is stabilized by the symphysis pubis and pubic rami, while posterior stability is provided by the sacroiliac (SI) complex and pelvic floor. Because the pelvis protects major vascular structures as well as genitourinary, gastrointestinal, gynecologic, neurologic, and musculoskeletal systems, fractures often coexist with life-threatening injuries and require urgent recognition and management.
Most pelvic fractures result from high-energy trauma. Approximately 65% are caused by vehicular mechanisms, including pedestrians struck by automobiles, while falls and crush injuries account for another 20%. Athletic, penetrating, and nontraumatic causes are less common. Mortality ranges from 6–19% and increases significantly in open fractures or when hemorrhagic shock is present. Unstable fractures, particularly those involving the posterior pelvis, are prone to severe hemorrhage due to disruption of arterial branches and venous plexuses, often with associated retroperitoneal hematoma. In children, hemorrhage may be more severe, and nonaccidental trauma must be considered. In pregnancy, pelvic fractures pose additional risk to the gravid uterus, including uterine rupture.
Clinically, patients typically present with pelvic, hip, groin, or lower back pain, often accompanied by swelling, ecchymosis, and tenderness. Many have associated injuries involving the abdomen, genitourinary tract, neurologic system, or vascular structures. Signs of pelvic instability, deformity, limb shortening or rotation, and inability to bear weight are concerning. In severe cases, hemorrhagic shock may dominate the presentation, with tachycardia, hypotension, altered mental status, and cool, pale extremities. Bleeding from the urethra, rectum, or vagina, as well as open wounds over the pelvis, suggests an open pelvic fracture.
Initial evaluation follows standard trauma principles. A single anteroposterior (AP) pelvic radiograph is the most important early diagnostic test and should be obtained promptly when pelvic fracture is suspected. Additional views such as inlet, outlet, or Judet oblique projections may further define injury patterns, particularly involving the posterior pelvis or acetabulum. Computed tomography (CT) provides detailed assessment of fracture anatomy, retroperitoneal hematoma, and associated visceral injuries, and CT angiography can identify arterial bleeding in hemodynamically stable patients. Focused abdominal sonography for trauma (FAST) may help detect intraperitoneal bleeding but has limited ability to distinguish pelvic from abdominal sources. Laboratory studies include type and cross-match, hemoglobin and hematocrit, platelet count, and coagulation profile.
Pelvic fractures are commonly categorized using the Tile classification system, which helps guide management. Type A fractures are stable and include avulsion injuries, isolated pubic rami fractures, and transverse sacral fractures. Type B fractures are rotationally unstable but vertically stable, such as open-book and lateral compression injuries. Type C fractures are both rotationally and vertically unstable, including vertical shear (Malgaigne) fractures, and are associated with the highest risk of hemorrhage and mortality. Acetabular fractures represent a distinct subgroup requiring specialized orthopedic evaluation.
Management priorities focus on rapid resuscitation, hemorrhage control, and stabilization. Early application of a pelvic binder or improvised sheet wrap at the level of the greater trochanters is critical in suspected unstable fractures, as it reduces pelvic volume and limits bleeding. Fluid resuscitation with crystalloids and early blood transfusion is indicated for shock, avoiding lower extremity IV access when possible. External fixation, angiographic embolization, or surgical pelvic packing may be required for ongoing hemorrhage. Type A fractures are generally managed conservatively with analgesia and mobilization as tolerated, whereas Type B and C fractures require urgent orthopedic and trauma consultation, close monitoring, and often operative intervention.
Patients with hemodynamic instability, unstable pelvic fractures, acetabular fractures, pelvic hemorrhage, or associated injuries should be admitted, frequently to the intensive care unit. Hemodynamically stable patients with isolated, stable Type A fractures and no other injuries may be discharged with appropriate analgesia and close orthopedic follow-up. A key clinical principle is that pelvic fractures signal high-energy trauma; clinicians must maintain a high index of suspicion for associated abdominal, genitourinary, vascular, and neurologic injuries. Early stabilization of the pelvis and management decisions guided by hemodynamic status are essential to improving outcomes.
Pelvic fractures account for approximately 3% of all bony fractures but are associated with disproportionately high morbidity and mortality. The pelvis consists of the sacrum and two innominate bones, each formed by the ilium, ischium, and pubis. Stability of the pelvic ring depends on strong ligamentous, muscular, and soft tissue support. The anterior pelvis is stabilized by the symphysis pubis and pubic rami, while posterior stability is provided by the sacroiliac (SI) complex and pelvic floor. Because the pelvis protects major vascular structures as well as genitourinary, gastrointestinal, gynecologic, neurologic, and musculoskeletal systems, fractures often coexist with life-threatening injuries and require urgent recognition and management.
Most pelvic fractures result from high-energy trauma. Approximately 65% are caused by vehicular mechanisms, including pedestrians struck by automobiles, while falls and crush injuries account for another 20%. Athletic, penetrating, and nontraumatic causes are less common. Mortality ranges from 6–19% and increases significantly in open fractures or when hemorrhagic shock is present. Unstable fractures, particularly those involving the posterior pelvis, are prone to severe hemorrhage due to disruption of arterial branches and venous plexuses, often with associated retroperitoneal hematoma. In children, hemorrhage may be more severe, and nonaccidental trauma must be considered. In pregnancy, pelvic fractures pose additional risk to the gravid uterus, including uterine rupture.
Clinically, patients typically present with pelvic, hip, groin, or lower back pain, often accompanied by swelling, ecchymosis, and tenderness. Many have associated injuries involving the abdomen, genitourinary tract, neurologic system, or vascular structures. Signs of pelvic instability, deformity, limb shortening or rotation, and inability to bear weight are concerning. In severe cases, hemorrhagic shock may dominate the presentation, with tachycardia, hypotension, altered mental status, and cool, pale extremities. Bleeding from the urethra, rectum, or vagina, as well as open wounds over the pelvis, suggests an open pelvic fracture.
Initial evaluation follows standard trauma principles. A single anteroposterior (AP) pelvic radiograph is the most important early diagnostic test and should be obtained promptly when pelvic fracture is suspected. Additional views such as inlet, outlet, or Judet oblique projections may further define injury patterns, particularly involving the posterior pelvis or acetabulum. Computed tomography (CT) provides detailed assessment of fracture anatomy, retroperitoneal hematoma, and associated visceral injuries, and CT angiography can identify arterial bleeding in hemodynamically stable patients. Focused abdominal sonography for trauma (FAST) may help detect intraperitoneal bleeding but has limited ability to distinguish pelvic from abdominal sources. Laboratory studies include type and cross-match, hemoglobin and hematocrit, platelet count, and coagulation profile.
Pelvic fractures are commonly categorized using the Tile classification system, which helps guide management. Type A fractures are stable and include avulsion injuries, isolated pubic rami fractures, and transverse sacral fractures. Type B fractures are rotationally unstable but vertically stable, such as open-book and lateral compression injuries. Type C fractures are both rotationally and vertically unstable, including vertical shear (Malgaigne) fractures, and are associated with the highest risk of hemorrhage and mortality. Acetabular fractures represent a distinct subgroup requiring specialized orthopedic evaluation.
Management priorities focus on rapid resuscitation, hemorrhage control, and stabilization. Early application of a pelvic binder or improvised sheet wrap at the level of the greater trochanters is critical in suspected unstable fractures, as it reduces pelvic volume and limits bleeding. Fluid resuscitation with crystalloids and early blood transfusion is indicated for shock, avoiding lower extremity IV access when possible. External fixation, angiographic embolization, or surgical pelvic packing may be required for ongoing hemorrhage. Type A fractures are generally managed conservatively with analgesia and mobilization as tolerated, whereas Type B and C fractures require urgent orthopedic and trauma consultation, close monitoring, and often operative intervention.
Patients with hemodynamic instability, unstable pelvic fractures, acetabular fractures, pelvic hemorrhage, or associated injuries should be admitted, frequently to the intensive care unit. Hemodynamically stable patients with isolated, stable Type A fractures and no other injuries may be discharged with appropriate analgesia and close orthopedic follow-up. A key clinical principle is that pelvic fractures signal high-energy trauma; clinicians must maintain a high index of suspicion for associated abdominal, genitourinary, vascular, and neurologic injuries. Early stabilization of the pelvis and management decisions guided by hemodynamic status are essential to improving outcomes.
- Published on
Emergency and Acute Medicine – Pelvic Inflammatory Disease
Pelvic inflammatory disease (PID) is an acute, community-acquired, sexually transmitted infection involving the upper female genital tract, including the uterus, fallopian tubes, ovaries, and adjacent pelvic structures. It is one of the most common gynecologic reasons for emergency department visits, accounting for hundreds of thousands of cases annually. PID represents a spectrum of disease rather than a single entity, and there is no definitive diagnostic gold standard. Because delayed treatment increases the risk of infertility, chronic pelvic pain, and ectopic pregnancy, clinicians must maintain a low threshold for diagnosis and initiate empiric antibiotic therapy when PID is suspected. Progressive or untreated infection may result in complications such as tubo-ovarian abscess (TOA). An important associated condition is Fitz-Hugh–Curtis syndrome, a perihepatic capsular inflammation that presents with sharp right upper quadrant pain worsened by movement, coughing, or inspiration.
The most important risk factors for PID include age younger than 25 years, multiple or symptomatic sexual partners, a prior history of PID, nonbarrier contraception, and certain demographic factors such as African American ethnicity. The most common causative organisms are *Chlamydia trachomatis* and *Neisseria gonorrhoeae*, although PID is frequently polymicrobial. Other implicated pathogens include group A and B streptococci, staphylococci, gram-negative rods such as *Escherichia coli*, *Klebsiella* spp., *Proteus* spp., and various anaerobes. Because of this broad microbiologic spectrum, treatment regimens must provide wide antimicrobial coverage.
Clinically, PID most often presents with bilateral lower abdominal or pelvic pain, which may range from mild and subtle to severe. Pain that worsens during intercourse or occurs shortly after or during menses is particularly suggestive. Associated symptoms commonly include abnormal vaginal discharge, abnormal uterine bleeding, dysmenorrhea, dyspareunia, dysuria, nausea, vomiting, fever, and chills. On examination, only about half of patients are febrile. Abdominal examination typically reveals lower quadrant tenderness, often bilateral, with possible rebound tenderness and decreased bowel sounds. Pelvic examination may demonstrate purulent endocervical discharge, cervical motion tenderness, and uterine or adnexal tenderness. Right upper quadrant tenderness in the context of PID suggests Fitz-Hugh–Curtis syndrome. Importantly, the absence of prominent uterine or adnexal tenderness should prompt consideration of alternative diagnoses.
The diagnosis of PID is primarily clinical and based on history and physical examination, including a pelvic exam. A pregnancy test is mandatory in all patients to exclude ectopic pregnancy or complications of intrauterine pregnancy. Minimum diagnostic criteria include the presence of lower abdominal tenderness, uterine or adnexal tenderness, or cervical motion tenderness. Supportive findings include fever above 38.3°C, abnormal cervical or vaginal discharge, leukocytosis, elevated inflammatory markers such as ESR or C-reactive protein, and microbiologic evidence of gonococcal or chlamydial infection. Laboratory studies may include a complete blood count, nucleic acid amplification testing for *N. gonorrhoeae* and *C. trachomatis*, and microscopic evaluation of vaginal discharge. Imaging is not routinely required but transvaginal ultrasound is indicated when adnexal fullness or mass is present, when TOA is suspected, when pelvic examination is limited, or when outpatient therapy fails.
Management depends on disease severity and patient reliability for follow-up. Most patients with mild to moderate PID can be treated as outpatients with intramuscular ceftriaxone or cefoxitin (with probenecid) plus oral doxycycline, with the addition of metronidazole when anaerobic coverage is indicated. Inpatient therapy is reserved for patients with severe illness, pregnancy, suspected TOA, immunodeficiency, inability to tolerate oral medications, failure of outpatient therapy, or concern for noncompliance. Recommended inpatient regimens include doxycycline combined with cefoxitin or cefotetan, or alternatives such as gentamicin plus clindamycin or ampicillin/sulbactam plus doxycycline. Parenteral therapy should continue for at least 24 hours after clinical improvement, followed by oral antibiotics to complete a 14-day course. Sexual partners should be evaluated and treated, and patients should receive counseling and testing for other sexually transmitted infections, including HIV.
Patients who do not meet admission criteria may be safely discharged with close follow-up arranged within 48–72 hours to ensure clinical improvement. Failure to improve within this timeframe warrants reassessment and possible inpatient management. Key clinical principles include recognizing that PID exists along a disease continuum, that early empiric treatment is essential to prevent long-term sequelae, and that quinolones and oral cephalosporins are no longer recommended in the United States for gonorrhea-related infections due to resistance. Comprehensive patient education, partner treatment, and reliable follow-up are critical components of effective PID management.
Pelvic inflammatory disease (PID) is an acute, community-acquired, sexually transmitted infection involving the upper female genital tract, including the uterus, fallopian tubes, ovaries, and adjacent pelvic structures. It is one of the most common gynecologic reasons for emergency department visits, accounting for hundreds of thousands of cases annually. PID represents a spectrum of disease rather than a single entity, and there is no definitive diagnostic gold standard. Because delayed treatment increases the risk of infertility, chronic pelvic pain, and ectopic pregnancy, clinicians must maintain a low threshold for diagnosis and initiate empiric antibiotic therapy when PID is suspected. Progressive or untreated infection may result in complications such as tubo-ovarian abscess (TOA). An important associated condition is Fitz-Hugh–Curtis syndrome, a perihepatic capsular inflammation that presents with sharp right upper quadrant pain worsened by movement, coughing, or inspiration.
The most important risk factors for PID include age younger than 25 years, multiple or symptomatic sexual partners, a prior history of PID, nonbarrier contraception, and certain demographic factors such as African American ethnicity. The most common causative organisms are *Chlamydia trachomatis* and *Neisseria gonorrhoeae*, although PID is frequently polymicrobial. Other implicated pathogens include group A and B streptococci, staphylococci, gram-negative rods such as *Escherichia coli*, *Klebsiella* spp., *Proteus* spp., and various anaerobes. Because of this broad microbiologic spectrum, treatment regimens must provide wide antimicrobial coverage.
Clinically, PID most often presents with bilateral lower abdominal or pelvic pain, which may range from mild and subtle to severe. Pain that worsens during intercourse or occurs shortly after or during menses is particularly suggestive. Associated symptoms commonly include abnormal vaginal discharge, abnormal uterine bleeding, dysmenorrhea, dyspareunia, dysuria, nausea, vomiting, fever, and chills. On examination, only about half of patients are febrile. Abdominal examination typically reveals lower quadrant tenderness, often bilateral, with possible rebound tenderness and decreased bowel sounds. Pelvic examination may demonstrate purulent endocervical discharge, cervical motion tenderness, and uterine or adnexal tenderness. Right upper quadrant tenderness in the context of PID suggests Fitz-Hugh–Curtis syndrome. Importantly, the absence of prominent uterine or adnexal tenderness should prompt consideration of alternative diagnoses.
The diagnosis of PID is primarily clinical and based on history and physical examination, including a pelvic exam. A pregnancy test is mandatory in all patients to exclude ectopic pregnancy or complications of intrauterine pregnancy. Minimum diagnostic criteria include the presence of lower abdominal tenderness, uterine or adnexal tenderness, or cervical motion tenderness. Supportive findings include fever above 38.3°C, abnormal cervical or vaginal discharge, leukocytosis, elevated inflammatory markers such as ESR or C-reactive protein, and microbiologic evidence of gonococcal or chlamydial infection. Laboratory studies may include a complete blood count, nucleic acid amplification testing for *N. gonorrhoeae* and *C. trachomatis*, and microscopic evaluation of vaginal discharge. Imaging is not routinely required but transvaginal ultrasound is indicated when adnexal fullness or mass is present, when TOA is suspected, when pelvic examination is limited, or when outpatient therapy fails.
Management depends on disease severity and patient reliability for follow-up. Most patients with mild to moderate PID can be treated as outpatients with intramuscular ceftriaxone or cefoxitin (with probenecid) plus oral doxycycline, with the addition of metronidazole when anaerobic coverage is indicated. Inpatient therapy is reserved for patients with severe illness, pregnancy, suspected TOA, immunodeficiency, inability to tolerate oral medications, failure of outpatient therapy, or concern for noncompliance. Recommended inpatient regimens include doxycycline combined with cefoxitin or cefotetan, or alternatives such as gentamicin plus clindamycin or ampicillin/sulbactam plus doxycycline. Parenteral therapy should continue for at least 24 hours after clinical improvement, followed by oral antibiotics to complete a 14-day course. Sexual partners should be evaluated and treated, and patients should receive counseling and testing for other sexually transmitted infections, including HIV.
Patients who do not meet admission criteria may be safely discharged with close follow-up arranged within 48–72 hours to ensure clinical improvement. Failure to improve within this timeframe warrants reassessment and possible inpatient management. Key clinical principles include recognizing that PID exists along a disease continuum, that early empiric treatment is essential to prevent long-term sequelae, and that quinolones and oral cephalosporins are no longer recommended in the United States for gonorrhea-related infections due to resistance. Comprehensive patient education, partner treatment, and reliable follow-up are critical components of effective PID management.
- Published on
Emergency and Acute Medicine – Pediatric Trauma
Pediatric trauma accounts for a significant cause of morbidity and mortality, with blunt trauma representing approximately 80% of cases and head injury present in most multisystem trauma. Trauma remains the leading cause of death and disability in children older than one year in developed countries. Young children are particularly vulnerable, with a high proportion of abuse-related injuries occurring in those younger than three years, especially infants under six months of age.
Most pediatric trauma results from single-system, minor blunt injuries. Common mechanisms include motor vehicle collisions, bicycle accidents, pedestrian versus vehicle incidents, and falls from height. Penetrating trauma is uncommon in younger children. Risk factors include inadequate supervision, developmental immaturity, poor judgment, risk-taking behaviors, and exposure to drugs or alcohol. Inconsistent history or injury patterns should raise concern for nonaccidental trauma.
History is typically obtained from caregivers, witnesses, or emergency personnel. Discrepancies between the history and observed injuries should prompt evaluation for abuse. Mechanism of injury alone is a poor predictor of severity, although certain factors such as handlebar injuries, intrusion into passenger space, lack of restraints, or absence of helmet use increase the likelihood of serious injury. A complete AMPLE history, including allergies, medications, past medical history, last oral intake, and events surrounding the injury, is essential.
Evaluation follows a structured primary survey using the ABCDE approach, addressing airway, breathing, circulation, disability, and exposure. Children may maintain compensation until significant blood loss occurs, after which rapid decompensation may follow. Unique anatomic features include a proportionally larger head, smaller blood volume, flexible chest wall, larger solid abdominal organs, and an intra-abdominal bladder in young children. Secondary survey focuses on detailed head-to-toe examination, including neurologic status, cervical spine assessment, chest and abdominal findings, extremity injuries, and skin evaluation. Certain injury patterns, such as lap belt syndrome or handlebar injuries, suggest specific internal injuries.
History and a thorough, age-appropriate physical examination are the cornerstone of evaluation. Routine trauma panels and blanket imaging are not evidence based in children and should be avoided. Laboratory testing and imaging should be individualized. Normal initial hemoglobin does not exclude hemorrhage. Elevated liver enzymes may guide abdominal imaging but should not be the sole determinant. Gross hematuria is concerning for genitourinary injury, while microscopic hematuria alone is not. Imaging decisions should be selective, with CT reserved for specific indications such as abnormal mental status, focal neurologic deficits, significant abdominal findings, or concerning mechanisms.
Prehospital priorities include rapid transport, airway stabilization, cervical spine immobilization, and hemorrhage control. In the emergency department, most children remain stable but require close monitoring. Management includes early oxygen, intravenous access with isotonic fluid resuscitation, pain control, blood transfusion if indicated, airway management when necessary, and treatment of identified injuries. Reassessment is critical, and family presence during resuscitation is encouraged when appropriate.
Admission is required for children with altered mental status, airway compromise, hemodynamic instability, significant imaging findings, operative injuries, suspected abuse, or lack of a reliable caregiver. Children with normal mental status, reassuring examinations, and negative indicated imaging may be safely discharged to reliable caregivers with appropriate instructions. Follow-up should be tailored to injuries sustained, with attention to potential post-traumatic stress, neurologic sequelae, and psychosocial needs.
Pediatric trauma accounts for a significant cause of morbidity and mortality, with blunt trauma representing approximately 80% of cases and head injury present in most multisystem trauma. Trauma remains the leading cause of death and disability in children older than one year in developed countries. Young children are particularly vulnerable, with a high proportion of abuse-related injuries occurring in those younger than three years, especially infants under six months of age.
Most pediatric trauma results from single-system, minor blunt injuries. Common mechanisms include motor vehicle collisions, bicycle accidents, pedestrian versus vehicle incidents, and falls from height. Penetrating trauma is uncommon in younger children. Risk factors include inadequate supervision, developmental immaturity, poor judgment, risk-taking behaviors, and exposure to drugs or alcohol. Inconsistent history or injury patterns should raise concern for nonaccidental trauma.
History is typically obtained from caregivers, witnesses, or emergency personnel. Discrepancies between the history and observed injuries should prompt evaluation for abuse. Mechanism of injury alone is a poor predictor of severity, although certain factors such as handlebar injuries, intrusion into passenger space, lack of restraints, or absence of helmet use increase the likelihood of serious injury. A complete AMPLE history, including allergies, medications, past medical history, last oral intake, and events surrounding the injury, is essential.
Evaluation follows a structured primary survey using the ABCDE approach, addressing airway, breathing, circulation, disability, and exposure. Children may maintain compensation until significant blood loss occurs, after which rapid decompensation may follow. Unique anatomic features include a proportionally larger head, smaller blood volume, flexible chest wall, larger solid abdominal organs, and an intra-abdominal bladder in young children. Secondary survey focuses on detailed head-to-toe examination, including neurologic status, cervical spine assessment, chest and abdominal findings, extremity injuries, and skin evaluation. Certain injury patterns, such as lap belt syndrome or handlebar injuries, suggest specific internal injuries.
History and a thorough, age-appropriate physical examination are the cornerstone of evaluation. Routine trauma panels and blanket imaging are not evidence based in children and should be avoided. Laboratory testing and imaging should be individualized. Normal initial hemoglobin does not exclude hemorrhage. Elevated liver enzymes may guide abdominal imaging but should not be the sole determinant. Gross hematuria is concerning for genitourinary injury, while microscopic hematuria alone is not. Imaging decisions should be selective, with CT reserved for specific indications such as abnormal mental status, focal neurologic deficits, significant abdominal findings, or concerning mechanisms.
Prehospital priorities include rapid transport, airway stabilization, cervical spine immobilization, and hemorrhage control. In the emergency department, most children remain stable but require close monitoring. Management includes early oxygen, intravenous access with isotonic fluid resuscitation, pain control, blood transfusion if indicated, airway management when necessary, and treatment of identified injuries. Reassessment is critical, and family presence during resuscitation is encouraged when appropriate.
Admission is required for children with altered mental status, airway compromise, hemodynamic instability, significant imaging findings, operative injuries, suspected abuse, or lack of a reliable caregiver. Children with normal mental status, reassuring examinations, and negative indicated imaging may be safely discharged to reliable caregivers with appropriate instructions. Follow-up should be tailored to injuries sustained, with attention to potential post-traumatic stress, neurologic sequelae, and psychosocial needs.
- Published on
KembaraXtra – Medicine – Molluscum Contagiosum
Molluscum contagiosum is a generally benign viral skin disease characterized by multiple small, painless, pearly papules. The infection is confined to the skin and mucous membranes and spreads through close personal contact or autoinoculation. It occurs worldwide with an estimated incidence of 2–8% and is more prevalent in tropical regions. Coinfection is common in immunocompromised patients, with up to 5–20% of individuals with HIV affected.
The condition is caused by a double-stranded DNA poxvirus of the Molluscipox genus. In children, transmission most commonly occurs through direct skin-to-skin contact, shared objects, or exposure to contaminated water such as swimming pools or baths. In adults, infection is most often acquired through sexual contact, although autoinoculation can occur at any age. Rarely, vertical transmission during childbirth has been reported.
After an incubation period of approximately 14–50 days, patients typically present with asymptomatic lesions, though mild pruritus or tenderness may occur. An eczematous reaction surrounding the lesions is seen in up to one-quarter of cases. In immunocompetent individuals, untreated lesions usually resolve spontaneously within several months but may persist for years. On examination, lesions appear as smooth, firm, dome-shaped papules measuring 2–6 mm in diameter. They may be flesh-colored, white, translucent, or light yellow and often contain a waxy, curd-like core composed of virion-rich material. A central umbilication is a classic feature, though it may be absent in some cases. Children most often have lesions on the face, trunk, and extremities, whereas healthy adults commonly have genital or lower abdominal involvement. In patients with HIV, lesions may be larger, disseminated, persistent, and involve the face, neck, and trunk, sometimes worsening with immune reconstitution after initiation of antiretroviral therapy.
Diagnosis is primarily clinical, based on history and characteristic skin findings. Skin biopsy may be performed when the diagnosis is uncertain. Adult men presenting with molluscum contagiosum should be evaluated for possible immunocompromise. In children, the condition is rarely associated with underlying immunodeficiency and typically does not require further investigation. Laboratory testing for immunosuppression, including HIV testing, may be indicated when lesions are extensive, atypical, or unexplained. Anogenital lesions warrant evaluation for other sexually transmitted infections.
Management is directed toward destruction or removal of infected epithelial cells to reduce autoinoculation and transmission. Active treatment is not always required, as lesions are self-limited in immunocompetent hosts. Immunocompromised patients are at higher risk for prolonged disease and secondary bacterial infection and more often require intervention. Physical treatment methods such as curettage, cryotherapy, or topical destructive agents are generally the most effective options. Patients should be advised to avoid scratching, shaving over lesions, sharing towels, contact sports, and swimming pools until lesions resolve. Sexual partners should be examined when genital involvement is present. Treated patients should be re-evaluated every 2–4 weeks, as multiple treatment sessions are often required.
Hospital admission is rarely necessary and is reserved for immunocompromised patients with extensive disease complicated by severe secondary infection. Most patients can be managed safely as outpatients, with dermatology referral considered when diagnosis is uncertain or disease is refractory to initial therapy. A key clinical pitfall is unnecessary aggressive treatment in immunocompetent patients, as observation alone is often appropriate, while failure to recognize underlying immunosuppression can delay appropriate management.
- Published on
KembaraXtra-Medicine – Mitral Valve Prolapse
Mitral valve prolapse (MVP) is characterized by bulging of one or both mitral valve leaflets into the left atrium during systole due to incomplete coaptation of the valve leaflets. It is most commonly caused by myxomatous degeneration of the valve, involving proliferation of the spongiosa layer with disruption of the fibrosa layer, along with excessive stretching of the chordae tendineae that places traction on the papillary muscles. Mitral regurgitation (MR) may develop in some patients. MVP typically presents between 10 and 16 years of age and is more common in females than males. It is generally benign in young women, whereas men over 50 years of age are more likely to develop severe regurgitation and require surgical intervention. MVP has a strong hereditary component and may be inherited in an autosomal dominant pattern with variable penetrance. A range of neuroendocrine and autonomic disturbances may also be associated with the condition.
MVP is associated with several connective tissue and systemic disorders, including Marfan syndrome, Ehlers–Danlos syndrome, osteogenesis imperfecta, pseudoxanthoma elasticum, Stickler syndrome, systemic lupus erythematosus, polyarteritis nodosa, polycystic kidney disease, von Willebrand disease, and Duchenne muscular dystrophy. These conditions contribute to abnormal connective tissue structure, predisposing the mitral valve to prolapse.
Clinical manifestations can be grouped into symptoms related to autonomic dysfunction, symptoms resulting from progression of mitral regurgitation, and complications such as stroke, infective endocarditis, or arrhythmias. Palpitations occur in up to 40% of patients and are commonly due to premature ventricular beats or paroxysmal supraventricular tachycardia. Chest pain occurs in about 10% of patients and is typically sharp, localized, nonexertional, and of variable duration. Dysautonomia-related symptoms include anxiety, panic attacks, fatigue, depression, migraine headaches, irritable bowel symptoms, and orthostatic intolerance. Syncope or presyncope is uncommon, occurring in less than 1% of cases, while dyspnea and fatigue are generally infrequent unless significant MR is present.
Physical examination classically reveals a mid-to-late systolic click best heard at the cardiac apex, often followed by a late systolic murmur. Maneuvers that reduce left ventricular volume, such as standing or Valsalva, cause the click to occur earlier in systole, while squatting delays it. Many patients exhibit skeletal abnormalities, including an asthenic body habitus, increased arm span relative to height, scoliosis or kyphosis, pectus excavatum, arachnodactyly, joint hypermobility, hypomastia, and a high-arched (“cathedral”) palate.
Diagnosis is often made clinically based on history and auscultation, with echocardiography used to confirm uncertain cases. On echocardiography, classic MVP is defined by superior displacement of the mitral leaflets greater than 2 mm into the left atrium during systole with leaflet thickness of at least 5 mm, while nonclassic MVP shows similar displacement with thinner leaflets. Electrocardiography is usually normal but may show ST-T wave changes, premature atrial or ventricular contractions, or QT prolongation. Chest radiography is typically normal unless significant MR leads to left atrial or ventricular enlargement.
Management is generally conservative, as many patients are asymptomatic and do not require treatment. β-blockers may be used for troublesome palpitations or chest pain, while magnesium supplementation may alleviate symptoms related to classic MVP syndrome. Orthostatic symptoms may respond to increased salt intake or fludrocortisone. Antiplatelet therapy is indicated in patients with transient ischemic attack or stroke. Significant MR, particularly in the presence of hypertension, may benefit from ACE inhibitors. Antibiotic prophylaxis is recommended only for selected patients with MVP and MR undergoing high-risk procedures, and is not indicated for isolated clicks without MR.
Hospital admission is reserved for patients with severe mitral regurgitation, ischemic chest pain, syncope, life-threatening arrhythmias, or cerebrovascular events. Asymptomatic patients without significant MR or dysrhythmias can be safely discharged. Cardiology referral is warranted for ventricular arrhythmias, evidence of disease progression, or risk of sudden death, while cardiothoracic surgical evaluation is indicated for symptomatic severe MR, reduced ejection fraction, pulmonary hypertension, or atrial fibrillation. Valve repair is preferred over replacement when feasible.
Regular follow-up every 3–5 years is recommended to monitor for progression of disease. Patients with MVP and MR should receive appropriate endocarditis prophylaxis during at-risk procedures and undergo evaluation before participating in high-intensity sports. A key clinical pitfall is attributing symptoms such as chest pain or syncope solely to MVP without appropriate evaluation, as MVP remains a recognized cause of sudden death in athletes.
Mitral valve prolapse (MVP) is characterized by bulging of one or both mitral valve leaflets into the left atrium during systole due to incomplete coaptation of the valve leaflets. It is most commonly caused by myxomatous degeneration of the valve, involving proliferation of the spongiosa layer with disruption of the fibrosa layer, along with excessive stretching of the chordae tendineae that places traction on the papillary muscles. Mitral regurgitation (MR) may develop in some patients. MVP typically presents between 10 and 16 years of age and is more common in females than males. It is generally benign in young women, whereas men over 50 years of age are more likely to develop severe regurgitation and require surgical intervention. MVP has a strong hereditary component and may be inherited in an autosomal dominant pattern with variable penetrance. A range of neuroendocrine and autonomic disturbances may also be associated with the condition.
MVP is associated with several connective tissue and systemic disorders, including Marfan syndrome, Ehlers–Danlos syndrome, osteogenesis imperfecta, pseudoxanthoma elasticum, Stickler syndrome, systemic lupus erythematosus, polyarteritis nodosa, polycystic kidney disease, von Willebrand disease, and Duchenne muscular dystrophy. These conditions contribute to abnormal connective tissue structure, predisposing the mitral valve to prolapse.
Clinical manifestations can be grouped into symptoms related to autonomic dysfunction, symptoms resulting from progression of mitral regurgitation, and complications such as stroke, infective endocarditis, or arrhythmias. Palpitations occur in up to 40% of patients and are commonly due to premature ventricular beats or paroxysmal supraventricular tachycardia. Chest pain occurs in about 10% of patients and is typically sharp, localized, nonexertional, and of variable duration. Dysautonomia-related symptoms include anxiety, panic attacks, fatigue, depression, migraine headaches, irritable bowel symptoms, and orthostatic intolerance. Syncope or presyncope is uncommon, occurring in less than 1% of cases, while dyspnea and fatigue are generally infrequent unless significant MR is present.
Physical examination classically reveals a mid-to-late systolic click best heard at the cardiac apex, often followed by a late systolic murmur. Maneuvers that reduce left ventricular volume, such as standing or Valsalva, cause the click to occur earlier in systole, while squatting delays it. Many patients exhibit skeletal abnormalities, including an asthenic body habitus, increased arm span relative to height, scoliosis or kyphosis, pectus excavatum, arachnodactyly, joint hypermobility, hypomastia, and a high-arched (“cathedral”) palate.
Diagnosis is often made clinically based on history and auscultation, with echocardiography used to confirm uncertain cases. On echocardiography, classic MVP is defined by superior displacement of the mitral leaflets greater than 2 mm into the left atrium during systole with leaflet thickness of at least 5 mm, while nonclassic MVP shows similar displacement with thinner leaflets. Electrocardiography is usually normal but may show ST-T wave changes, premature atrial or ventricular contractions, or QT prolongation. Chest radiography is typically normal unless significant MR leads to left atrial or ventricular enlargement.
Management is generally conservative, as many patients are asymptomatic and do not require treatment. β-blockers may be used for troublesome palpitations or chest pain, while magnesium supplementation may alleviate symptoms related to classic MVP syndrome. Orthostatic symptoms may respond to increased salt intake or fludrocortisone. Antiplatelet therapy is indicated in patients with transient ischemic attack or stroke. Significant MR, particularly in the presence of hypertension, may benefit from ACE inhibitors. Antibiotic prophylaxis is recommended only for selected patients with MVP and MR undergoing high-risk procedures, and is not indicated for isolated clicks without MR.
Hospital admission is reserved for patients with severe mitral regurgitation, ischemic chest pain, syncope, life-threatening arrhythmias, or cerebrovascular events. Asymptomatic patients without significant MR or dysrhythmias can be safely discharged. Cardiology referral is warranted for ventricular arrhythmias, evidence of disease progression, or risk of sudden death, while cardiothoracic surgical evaluation is indicated for symptomatic severe MR, reduced ejection fraction, pulmonary hypertension, or atrial fibrillation. Valve repair is preferred over replacement when feasible.
Regular follow-up every 3–5 years is recommended to monitor for progression of disease. Patients with MVP and MR should receive appropriate endocarditis prophylaxis during at-risk procedures and undergo evaluation before participating in high-intensity sports. A key clinical pitfall is attributing symptoms such as chest pain or syncope solely to MVP without appropriate evaluation, as MVP remains a recognized cause of sudden death in athletes.
- Published on
KembaraXtra-Medicine – Methemoglobinemia
Methemoglobinemia is a condition in which the iron molecule within hemoglobin is oxidized from the ferrous (Fe²⁺) state to the ferric (Fe³⁺) state, producing methemoglobin, a form of hemoglobin that is unable to transport oxygen. As a result, the effective oxygen-carrying capacity of blood is reduced, leading to tissue hypoxia and cyanosis at significant levels. Normal methemoglobin levels are ≤1%, and symptoms typically develop when levels exceed 20%. The condition is more severe in patients with coexisting anemia. Methemoglobin causes functional anemia by reducing total oxygen delivery and shifts the hemoglobin–oxygen dissociation curve to the left, impairing oxygen release to tissues. Under normal circumstances, methemoglobin levels are maintained at physiologic ranges by NADH-dependent methemoglobin (cytochrome B5) reductase in red blood cells.
Methemoglobinemia may be congenital or acquired. Congenital forms are usually due to NADH–methemoglobin (cytochrome B5) reductase deficiency, which may be homozygous or heterozygous, or due to abnormal hemoglobins such as hemoglobin M. Acquired methemoglobinemia results from oxidative stress on red blood cells caused by various drugs and chemicals. Some agents act as direct oxidants, such as nitrites, while others cause oxidant injury through N-hydroxylamine metabolites. Onset may be delayed after exposure. Many causative agents also produce Heinz body hemolytic anemia through oxidative damage to red blood cell proteins, particularly in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Therefore, patients diagnosed with methemoglobinemia should also be evaluated for hemolysis. In some cases, methemoglobinemia may serve as a marker for underlying genetic susceptibility, such as heterozygous cytochrome B5 reductase deficiency.
Numerous substances are associated with acquired methemoglobinemia. These include cyanide antidote kits containing amyl or sodium nitrite, nitrates and nitrites (including nitroglycerin via metabolic conversion), nitric oxide, aniline dyes, excessive methylene blue, antiparasitic agents such as dapsone, primaquine, and chloroquine, and local anesthetics including benzocaine, lidocaine, and prilocaine. Other implicated agents include phenazopyridine, phenacetin, nitrofurantoin, sulfonamides, metoclopramide, naphthalene, paraquat, arsine gas, chlorates, and phenolic compounds.
Clinically, methemoglobinemia presents with central cyanosis that does not improve with supplemental oxygen. In nonanemic patients, cyanosis becomes apparent when methemoglobin levels reach approximately 10–15% of total hemoglobin. Additional symptoms include dyspnea, tachypnea, chest pain, dysrhythmias, syncope, and altered mental status, particularly when levels exceed 50%. History should focus on exposure to oxidant agents, timing and amount of ingestion, presence of G6PD deficiency, and comorbid conditions that impair oxygen delivery, such as coronary artery disease. Physical examination typically reveals cyanosis, with particular attention required for neurologic and cardiovascular findings. Signs of hemolytic anemia, such as icterus or dark-colored urine, may also be present.
Diagnostic evaluation requires recognition that pulse oximetry is unreliable in methemoglobinemia. Methemoglobin interferes with pulse oximeter readings, often producing a saturation near 85% regardless of severity, and therefore cannot be used to guide management. Arterial blood gas analysis with co-oximetry is essential to directly measure methemoglobin levels, assess oxygenation, and exclude other dyshemoglobinemias such as carboxyhemoglobinemia. The blood may appear characteristically chocolate brown. Additional investigations include a complete blood count with peripheral smear to evaluate for hemolysis and chest radiography to exclude alternative pulmonary causes of hypoxia.
Initial management focuses on airway, breathing, and circulation stabilization, cardiac monitoring, intravenous fluids for hypotension, administration of supplemental oxygen, and treatment of hypoglycemia or altered mental status as indicated. If recent ingestion is suspected and airway reflexes are intact, activated charcoal may be administered. The source of oxidant stress must be identified and removed. Methylene blue is the treatment of choice for significant methemoglobinemia and is indicated in symptomatic patients with levels above 10–20% or asymptomatic patients with levels above 30%. Transient worsening of pulse oximetry readings after methylene blue administration is expected and does not require intervention. Caution is required in patients with G6PD deficiency, as methylene blue may precipitate hemolysis. Lack of response should prompt consideration of continued exposure or alternative diagnoses such as sulfhemoglobinemia, which does not respond to methylene blue.
In severe or refractory cases, red blood cell transfusion may be required to improve oxygen-carrying capacity, particularly when hemolysis is present. Exchange transfusion may be necessary in neonates and infants. Hyperbaric oxygen therapy can be considered in life-threatening cases when immediately available, as it enhances oxygen delivery independent of hemoglobin. Children and neonates are at higher risk, may develop delayed symptoms after seemingly minor exposures, and often require prolonged observation due to reduced methemoglobin reductase activity.
Hospital admission is indicated for severely symptomatic patients, those requiring repeated doses of methylene blue, or cases associated with prolonged or recurrent methemoglobinemia such as dapsone exposure. Patients may be discharged once methemoglobin levels fall below 20%, are trending downward, and symptoms have resolved in the absence of significant comorbid disease. Toxicology consultation is recommended for significant exposures, and occupational medicine follow-up is appropriate for work-related cases. Key clinical pitfalls include reliance on pulse oximetry instead of arterial blood gas with co-oximetry and delayed administration of methylene blue in symptomatic patients.
Methemoglobinemia is a condition in which the iron molecule within hemoglobin is oxidized from the ferrous (Fe²⁺) state to the ferric (Fe³⁺) state, producing methemoglobin, a form of hemoglobin that is unable to transport oxygen. As a result, the effective oxygen-carrying capacity of blood is reduced, leading to tissue hypoxia and cyanosis at significant levels. Normal methemoglobin levels are ≤1%, and symptoms typically develop when levels exceed 20%. The condition is more severe in patients with coexisting anemia. Methemoglobin causes functional anemia by reducing total oxygen delivery and shifts the hemoglobin–oxygen dissociation curve to the left, impairing oxygen release to tissues. Under normal circumstances, methemoglobin levels are maintained at physiologic ranges by NADH-dependent methemoglobin (cytochrome B5) reductase in red blood cells.
Methemoglobinemia may be congenital or acquired. Congenital forms are usually due to NADH–methemoglobin (cytochrome B5) reductase deficiency, which may be homozygous or heterozygous, or due to abnormal hemoglobins such as hemoglobin M. Acquired methemoglobinemia results from oxidative stress on red blood cells caused by various drugs and chemicals. Some agents act as direct oxidants, such as nitrites, while others cause oxidant injury through N-hydroxylamine metabolites. Onset may be delayed after exposure. Many causative agents also produce Heinz body hemolytic anemia through oxidative damage to red blood cell proteins, particularly in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Therefore, patients diagnosed with methemoglobinemia should also be evaluated for hemolysis. In some cases, methemoglobinemia may serve as a marker for underlying genetic susceptibility, such as heterozygous cytochrome B5 reductase deficiency.
Numerous substances are associated with acquired methemoglobinemia. These include cyanide antidote kits containing amyl or sodium nitrite, nitrates and nitrites (including nitroglycerin via metabolic conversion), nitric oxide, aniline dyes, excessive methylene blue, antiparasitic agents such as dapsone, primaquine, and chloroquine, and local anesthetics including benzocaine, lidocaine, and prilocaine. Other implicated agents include phenazopyridine, phenacetin, nitrofurantoin, sulfonamides, metoclopramide, naphthalene, paraquat, arsine gas, chlorates, and phenolic compounds.
Clinically, methemoglobinemia presents with central cyanosis that does not improve with supplemental oxygen. In nonanemic patients, cyanosis becomes apparent when methemoglobin levels reach approximately 10–15% of total hemoglobin. Additional symptoms include dyspnea, tachypnea, chest pain, dysrhythmias, syncope, and altered mental status, particularly when levels exceed 50%. History should focus on exposure to oxidant agents, timing and amount of ingestion, presence of G6PD deficiency, and comorbid conditions that impair oxygen delivery, such as coronary artery disease. Physical examination typically reveals cyanosis, with particular attention required for neurologic and cardiovascular findings. Signs of hemolytic anemia, such as icterus or dark-colored urine, may also be present.
Diagnostic evaluation requires recognition that pulse oximetry is unreliable in methemoglobinemia. Methemoglobin interferes with pulse oximeter readings, often producing a saturation near 85% regardless of severity, and therefore cannot be used to guide management. Arterial blood gas analysis with co-oximetry is essential to directly measure methemoglobin levels, assess oxygenation, and exclude other dyshemoglobinemias such as carboxyhemoglobinemia. The blood may appear characteristically chocolate brown. Additional investigations include a complete blood count with peripheral smear to evaluate for hemolysis and chest radiography to exclude alternative pulmonary causes of hypoxia.
Initial management focuses on airway, breathing, and circulation stabilization, cardiac monitoring, intravenous fluids for hypotension, administration of supplemental oxygen, and treatment of hypoglycemia or altered mental status as indicated. If recent ingestion is suspected and airway reflexes are intact, activated charcoal may be administered. The source of oxidant stress must be identified and removed. Methylene blue is the treatment of choice for significant methemoglobinemia and is indicated in symptomatic patients with levels above 10–20% or asymptomatic patients with levels above 30%. Transient worsening of pulse oximetry readings after methylene blue administration is expected and does not require intervention. Caution is required in patients with G6PD deficiency, as methylene blue may precipitate hemolysis. Lack of response should prompt consideration of continued exposure or alternative diagnoses such as sulfhemoglobinemia, which does not respond to methylene blue.
In severe or refractory cases, red blood cell transfusion may be required to improve oxygen-carrying capacity, particularly when hemolysis is present. Exchange transfusion may be necessary in neonates and infants. Hyperbaric oxygen therapy can be considered in life-threatening cases when immediately available, as it enhances oxygen delivery independent of hemoglobin. Children and neonates are at higher risk, may develop delayed symptoms after seemingly minor exposures, and often require prolonged observation due to reduced methemoglobin reductase activity.
Hospital admission is indicated for severely symptomatic patients, those requiring repeated doses of methylene blue, or cases associated with prolonged or recurrent methemoglobinemia such as dapsone exposure. Patients may be discharged once methemoglobin levels fall below 20%, are trending downward, and symptoms have resolved in the absence of significant comorbid disease. Toxicology consultation is recommended for significant exposures, and occupational medicine follow-up is appropriate for work-related cases. Key clinical pitfalls include reliance on pulse oximetry instead of arterial blood gas with co-oximetry and delayed administration of methylene blue in symptomatic patients.
